Updated at 5 p.m. Nov. 14: Sienna Biopharmaceuticals announced Nov. 14 that it would put itself up for sale after a bankruptcy court approved its proposed timeline for a bidding process. All bids to acquire the company’s assets are due to independent financial adviser Cowen and Company before 5 p.m. Eastern time on Dec. 2.…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
